Cargando…

Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy

Cancer chemotherapy targeting frequent loss of heterozygosity events is an attractive concept, since tumor cells may lack enzymatic activities present in normal constitutional cells. To find exploitable targets, we map prevalent genetic polymorphisms to protein structures and identify 45 nsSNVs (non...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rendo, Veronica, Stoimenov, Ivaylo, Mateus, André, Sjöberg, Elin, Svensson, Richard, Gustavsson, Anna-Lena, Johansson, Lars, Ng, Adrian, OʼBrien, Casey, Giannakis, Marios, Artursson, Per, Nygren, Peter, Cheong, Ian, Sjöblom, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066191/ https://www.ncbi.nlm.nih.gov/pubmed/32161261 http://dx.doi.org/10.1038/s41467-020-15111-4

Ejemplares similares

Targeting tumor vulnerabilities associated with loss of heterozygosity
por: Rendo, Veronica, et al.
Publicado: (2020)

Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer
por: Rendo, Veronica, et al.
Publicado: (2020)

Computational and molecular tools for scalable rAAV-mediated genome editing
por: Stoimenov, Ivaylo, et al.
Publicado: (2015)

Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth
por: Pandzic, Tatjana, et al.
Publicado: (2017)

Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis
por: Kundu, Snehangshu, et al.
Publicado: (2021)

Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy
por: Zhang, Xiaonan, et al.
Publicado: (2021)

Allelic sequence heterozygosity in single Giardia parasites
por: Ankarklev, Johan, et al.
Publicado: (2012)

The PCNA pseudogenes in the human genome
por: Stoimenov, Ivaylo, et al.
Publicado: (2012)

Pleiotropic associations of heterozygosity for the SERPINA1 Z allele in the UK Biobank
por: Fawcett, Katherine A., et al.
Publicado: (2021)

Heterozygosity of the Alpha 1‐Antitrypsin Pi*Z Allele and Risk of Liver Disease
por: Hakim, Aaron, et al.
Publicado: (2021)

A High-Throughput Cell-Based Method to Predict the Unbound Drug Fraction in the Brain
por: Mateus, André, et al.
Publicado: (2014)

Heterozygosity for the alpha‐1‐antitrypsin Z allele in cirrhosis is associated with more advanced disease
por: Schaefer, Benedikt, et al.
Publicado: (2018)

Effect of human leukocyte antigen heterozygosity on infectious disease outcome: The need for allele-specific measures
por: Lipsitch, Marc, et al.
Publicado: (2003)

Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles
por: Fauvert, Delphine, et al.
Publicado: (2009)

Transcription Inhibition by DRB Potentiates Recombinational Repair of UV Lesions in Mammalian Cells
por: Stoimenov, Ivaylo, et al.
Publicado: (2011)

Diagnostic value of DNA alteration: loss of heterozygosity or allelic imbalance—promising for molecular staging of prostate cancers
por: Bryś, Magdalena, et al.
Publicado: (2013)

Allele-specific genome editing using CRISPR–Cas9 is associated with loss of heterozygosity in diploid yeast
por: Gorter de Vries, Arthur R, et al.
Publicado: (2019)

Genetic Diversity of the Flavohemoprotein Gene of Giardia lamblia: Evidence for High Allelic Heterozygosity and Copy Number Variation
por: Saghaug, Christina S, et al.
Publicado: (2020)

Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors
por: Kryh, Hanna, et al.
Publicado: (2011)

Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays
por: Staaf, Johan, et al.
Publicado: (2008)

Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer
por: Ciani, Yari, et al.
Publicado: (2022)

Exploiting the antiviral potential of intermetallic nanoparticles
por: Matharu, Rupy Kaur, et al.
Publicado: (2021)

A new method to detect loss of heterozygosity using cohort heterozygosity comparisons
por: Green, Michael R, et al.
Publicado: (2010)

Inference of Gene Regulatory Networks with Sparse Structural Equation Models Exploiting Genetic Perturbations
por: Cai, Xiaodong, et al.
Publicado: (2013)

CHK1 activity is required for continuous replication fork elongation but not stabilization of post-replicative gaps after UV irradiation
por: Elvers, Ingegerd, et al.
Publicado: (2012)

Analysis of p16 expression and allelic imbalance / loss of heterozygosity of 9p21 in cutaneous squamous cell carcinomas
por: Gray, Sarah E, et al.
Publicado: (2006)

HLA Class I and II alleles, heterozygosity and HLA-KIR interactions are associated with rates of genital HSV shedding and lesions
por: Magaret, Amalia, et al.
Publicado: (2016)

Genetic Profiling Reveals High Allelic Diversity, Heterozygosity and Antigenic Diversity in the Clinical Isolates of the Theileria annulata From India
por: Roy, Sonti, et al.
Publicado: (2019)

Relationship between Allelic Heterozygosity in BoLA-DRB3 and Proviral Loads in Bovine Leukemia Virus-Infected Cattle
por: Daous, Hala El, et al.
Publicado: (2021)

Perivascular Neuropilin‐1 expression is an independent marker of improved survival in renal cell carcinoma
por: Morin, Eric, et al.
Publicado: (2020)

Assessment of Heterozygosity and Genome-Wide Analysis of Heterozygosity Regions in Two Duroc Pig Populations
por: Ruan, Donglin, et al.
Publicado: (2022)

Improved predictions of time-dependent drug-drug interactions by determination of cytosolic drug concentrations
por: Filppula, Anne M., et al.
Publicado: (2019)

Loss of heterozygosity: what is it good for?
por: Ryland, Georgina L., et al.
Publicado: (2015)

Reduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD gene
por: Maring, J G, et al.
Publicado: (2002)

An improved Diagnostic PCR Assay for identification of Cryptic Heterozygosity for CGG Triplet Repeat Alleles in the Fragile X Gene (FMR1)
por: Khaniani, Mahmoud S, et al.
Publicado: (2008)

Change in Methylation Status of DNA of Remaining Allele in Human Lung Cancers with Loss of Heterozygosity on Chromosomes 3p and 13q
por: Shiraishi, Masahiko, et al.
Publicado: (1989)

Intracellular drug bioavailability: a new predictor of system dependent drug disposition
por: Mateus, André, et al.
Publicado: (2017)

Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma
por: Khadse, Anand, et al.
Publicado: (2022)

VEGF receptor‐2/neuropilin 1 trans‐complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival
por: Morin, Eric, et al.
Publicado: (2018)

Genomic mechanisms of immune evasion in colorectal cancer: from discovery to clinical practice
por: Grasso, Catherine S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2feeioi96trnltesl090tf9cc8